Insiders Adhera Therapeutics, Inc.

Equities

ATRX

US00687E4061

Delayed OTC Markets Other stock markets 11:13:06 2024-05-17 am EDT			5-day change	1st Jan Change
0.008 ^USD	-1.23%		-1.23%	-73.33%

Jan. 18	Adhera Therapeutics, Inc. Receives Written Notice from Melior Pharmaceuticals II, LLC of Election to Terminate the License Agreement	CI
Jan. 16	Adhera Therapeutics, Inc. Announces the Resignation of Zahed Subhan as Chief Executive Officer	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Adhera Therapeutics, Inc. Announces the Resignation of Zahed Subhan as Chief Executive Officer	Jan. 16	CI
Adhera Therapeutics, Inc. Announces Board Resignations	Jan. 16	CI
Adhera Therapeutics, Inc. Elects Zahed Subhan as Chairman of the Board	22-09-19	CI
Adhera Therapeutics, Inc. Announces CEO Changes, Effective September 30, 2022	22-09-09	CI
Adhera Therapeutics, Inc. Appoints Andrew Kucharchuk as Chief Operating Officer, Effective September 30, 2022	22-09-09	CI
Adhera Therapeutics, Inc. Appoints Trond K. Waerness as Chairman of the Board	22-05-19	CI
Adhera Therapeutics, Inc. Appoints Jean Buteau to Scientific Advisory Board	22-03-21	CI
Adhera Therapeutics, Inc. Announces Appointment of Zahed Subhan to its Board of Directors	21-11-08	CI
Adhera Therapeutics, Inc. Appoints Andrew G. Reaume to Board of Directors	21-09-09	CI
Adhera Therapeutics, Inc. Appoints Trond K. Waerness as Member of its Board of Directors	21-04-23	CI
Adhera Therapeutics, Inc. Appoints Andrew Kucharchuk as the Chief Executive Officer	20-07-13	CI
Adhera Therapeutics, Inc. Announces Management Changes	20-07-13	CI
Adhera Therapeutics, Inc. Announces Resignation of Rhonda Stanley, Senior Vice President of Finance & Accounting	20-07-13	CI
Adhera Therapeutics, Inc. Announces Resignation of Tim Boris as Member of the Board of Directors and All Committees	20-06-17	CI
Adhera Therapeutics, Inc. Announces Nancy R. Phelan Has Resigned as Chief Executive Officer, Effective June 15, 2020	20-06-11	CI
Adhera Therapeutics, Inc. announces management changes, effective June 15, 2020	20-06-11	CI
Nancy R. Phelan Replaces Robert C. Moscato as Chief Executive Officer of Adhera Therapeutics, Inc	19-04-04	CI
Adhera Therapeutics, Inc. Announces Resignation of Eric Teague as Chief Financial Officer, Effective March 22, 2019	19-03-15	CI
Adhera Therapeutics, Inc. Announces Resignation of Erik Emerson as Chief Commercial Officer	19-01-22	CI
Marina Biotech, Inc. will Change its Name to Adhera Therapeutics Inc	18-10-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Adhera Therapeutics, Inc.

Equities

ATRX

US00687E4061

Insiders

Filters